v3.24.3
Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)
$ in Thousands
 3 Months Ended 9 Months Ended 12 Months Ended
Sep. 30, 2024
Sep. 30, 2023
Sep. 30, 2024
Sep. 30, 2023
Dec. 31, 2023
Cash Flows From Operating Activities:          
Net loss for the period $ 1,990 $ (2,783) $ 1,722 $ (11,819)  
Adjustments to reconcile net loss to net cash used in operating activities:          
Depreciation and amortization     646 675  
Share-based compensation     1,814 1,648  
Warranty provision     (37) (8)  
Change in fair value of warrant liabilities (5,600) 117 (12,517) 117  
Non-cash lease expense     217 80  
Provision for doubtful accounts     (89) (48)  
Inventory obsolescence reserve     12 0  
Changes in assets and liabilities:          
Accounts receivable     2,337 (1,353)  
Inventories     (529) (1,780)  
Prepaid expenses and other current assets     666 13  
Accounts payable     168 (67)  
Operating lease liability     (99) (80)  
Customer deposits     (956) 2  
Accrued liabilities and other     (370) (322)  
Warranty settlement     (42) (8)  
Deferred Revenue     130 32  
Changes in other non-current assets and goodwill     8 0  
Net cash used in operating activities     (6,919) (12,918)  
Cash Flows From Investing Activities:          
Purchase of short-term investments       (6,145)  
Proceeds from maturities of short-term investments     7,500 10,000  
Capital expenditures for property and equipment     (13) (133)  
Net cash paid for acquisition of Intrensic     0 (551)  
Proceeds (cash outlay for) ) long-term deposits     0 (66)  
Net cash provided by investing activities     7,363 2,768  
Cash Flows From Financing Activities:          
Proceeds from exercise of stock options     588 0  
Proceeds from issuance of warrants and convertible preferred stock, net of offering costs     0 9,754  
Dividends settled in Cash     (120) 0  
Net cash provided by financing activities     468 9,754  
Net (decrease) increase in cash and cash equivalents     912 (396)  
Cash and cash equivalents, beginning of period     3,955 5,330 $ 5,330
Cash and cash equivalents, end of period $ 4,867 $ 4,934 4,867 4,934 $ 3,955
Supplemental Disclosure of Non-Cash Investing and Financing Activities:          
Change in unrealized gain on short-term investments     94 (94)  
Net assets acquired from acquisition     0 147  
Warrant liabilities     0 (7,834)  
Dividends on convertible preferred stock     (1,017) (193)  
Dividends settled with common stock     140 0  
Convertible Preferred Stock [Member]          
Supplemental Disclosure of Non-Cash Investing and Financing Activities:          
Issuance of common stock for acquisition     0 (2,036)  
Convertible preferred stock issued, net of offering costs     0 (2,036)  
Intrensic, LLC [Member]          
Supplemental Disclosure of Non-Cash Investing and Financing Activities:          
Issuance of common stock for acquisition     0 (1,938)  
Convertible preferred stock issued, net of offering costs     0 (1,938)  
Patents and Trademarks [Member]          
Cash Flows From Investing Activities:          
Investment in patents and trademarks     (124) (277)  
Intangibles Other than Patents and Trademarks [Member]          
Cash Flows From Investing Activities:          
Investment in patents and trademarks     $ 0 $ (60)  

Source

PDF HTML
ZIP